[
  {
    "report_key": "2026:q1",
    "period_label": "2026 Q1",
    "date": "2026-04-29",
    "title": "Kvartalsrapport Q1 2026",
    "original_title": "BioInvent International AB: Delårsrapport januari - mars 2026",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=be158a6dd3920b5c915eb1cf51aaf26d9&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2026,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
        "title": "Kvartalsrapport Q1 2026",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a765f877b02a605a235a412ef9ad999ae",
        "date": "2026-04-29",
        "period": "2026-q1",
        "form_type": "interim-report",
        "report_key": "2026:q1",
        "filename": "BioInvent_2026_Q1_SE.pdf",
        "text_chars": 52183,
        "sha256": "760646253561e826b991c899b5cef3cb5011cd352be5ea975efff2c17d64c8de",
        "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
        "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
        "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
            "chars": 52183
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:annual",
    "period_label": "2025 Årsredovisning",
    "date": "2026-03-31",
    "title": "Årsredovisning 2025",
    "original_title": "BioInvent International AB publicerar årsredovisningen för 2025",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b63c54630b6b77a174e8fb86a1012f0ba&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2025,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2025",
        "title": "Årsredovisning 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a487fe042126ce0a635def2e18fe5d002",
        "date": "2026-03-31",
        "period": "2025-annual",
        "form_type": "annual-report",
        "report_key": "2025:annual",
        "filename": "BioInvent_AR_2025_SE.pdf",
        "text_chars": 256078,
        "sha256": "efdccbf6e381225957a5e1d1ec52affbf07ebb50fb74e59db702d78f170bc384",
        "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2025",
        "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2025",
        "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
            "chars": 179786
          },
          {
            "number": 2,
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
            "chars": 76290
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q4",
    "period_label": "2025 Q4",
    "date": "2026-02-26",
    "title": "Kvartalsrapport Q4 2025",
    "original_title": "BioInvent International AB: Bokslutskommuniké 1 januari - 31 december 2025",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b63f1fa8542a4e536857a93ea14af0df4&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2025,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
        "title": "Kvartalsrapport Q4 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a7d93f053ec21ea8d08e351a192d6fb13",
        "date": "2026-02-26",
        "period": "2025-q4",
        "form_type": "year-end-report",
        "report_key": "2025:q4",
        "filename": "BioInvent_Q4_2025_SE_Final.pdf",
        "text_chars": 64011,
        "sha256": "2d2727acac874bdb56f04acbbf3713f8b0f0cd5c63ed787ec40a0efb43b0e2a1",
        "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
        "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
        "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
            "chars": 64011
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q3",
    "period_label": "2025 Q3",
    "date": "2025-10-29",
    "title": "Kvartalsrapport Q3 2025",
    "original_title": "BioInvent International AB: Delårsrapport januari - september 2025",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b758b8ef9cd3ea8cc78fd117758642c86&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
        "title": "Kvartalsrapport Q3 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/aaf62030777dde1c77b31a87decc7bd13",
        "date": "2025-10-29",
        "period": "2025-q3",
        "form_type": "interim-report",
        "report_key": "2025:q3",
        "filename": "BioInvent_Q3_2025_SE.pdf",
        "text_chars": 62170,
        "sha256": "aa97c4a88aa00b4c59994f746f13afa80d91ae6f51ceda1f600b038aab6b10e4",
        "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
        "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
        "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
            "chars": 62170
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q2",
    "period_label": "2025 Q2",
    "date": "2025-08-26",
    "title": "Kvartalsrapport Q2 2025",
    "original_title": "BioInvent International AB: Delårsrapport januari - juni 2025",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b5be98a3ef48295226895d8270ed14d8e&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
        "title": "Kvartalsrapport Q2 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/ad1e4a43e2a0a70f0f24a5ec5030dc63b",
        "date": "2025-08-26",
        "period": "2025-q2",
        "form_type": "interim-report",
        "report_key": "2025:q2",
        "filename": "BioInvent_Q2_2025_SE_25_Augusti.pdf",
        "text_chars": 58410,
        "sha256": "eeb118e6a4b98d146a147018439761cecf789891a2277744590fe9fb3634b4ce",
        "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
        "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
        "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
            "chars": 58410
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2025:q1",
    "period_label": "2025 Q1",
    "date": "2025-04-29",
    "title": "Kvartalsrapport Q1 2025",
    "original_title": "BioInvent International AB: Delårsrapport januari - mars 2025",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b4ead05c5608663c73175af63f2171ab2&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2025,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
        "title": "Kvartalsrapport Q1 2025",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a93fd97dcbb69c06a98bbca3d7915bb01",
        "date": "2025-04-29",
        "period": "2025-q1",
        "form_type": "interim-report",
        "report_key": "2025:q1",
        "filename": "BioInvent_Q1_2025_SE.pdf",
        "text_chars": 56957,
        "sha256": "1bde995565aefd97353a9ada785e5cca9fced64bec2afdf11882a57e3c20d3ba",
        "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
        "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
        "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
            "chars": 56957
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:annual",
    "period_label": "2024 Årsredovisning",
    "date": "2025-04-04",
    "title": "Årsredovisning 2024",
    "original_title": "BioInvent International AB publicerar årsredovisningen för 2024",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b1b104722ee5caed8feac68349be1c315&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2024,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2024",
        "title": "Årsredovisning 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a81b8869e169747bb6eb2e0628e40d1c6",
        "date": "2025-04-04",
        "period": "2024-annual",
        "form_type": "annual-report",
        "report_key": "2024:annual",
        "filename": "BioInvent_AR_2024_SE_FINAL.pdf",
        "text_chars": 264240,
        "sha256": "01966b16031def74138efc849144ab9f45c904525300f2a9102c2b212247dd63",
        "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2024",
        "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2024",
        "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
            "chars": 173839
          },
          {
            "number": 2,
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
            "chars": 90399
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q4",
    "period_label": "2024 Q4",
    "date": "2025-02-27",
    "title": "Kvartalsrapport Q4 2024",
    "original_title": "BioInvent International AB: Bokslutskommuniké 1 januari - 31 december 2024",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b4325ea86558e37754645d98a44d9fcb9&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2024,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
        "title": "Kvartalsrapport Q4 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a4e46e0f8f95e50791a1efc8f5291065e",
        "date": "2025-02-27",
        "period": "2024-q4",
        "form_type": "year-end-report",
        "report_key": "2024:q4",
        "filename": "BioInvent_Q4_2024_SE_Final.pdf",
        "text_chars": 63027,
        "sha256": "84f9d860cd29baa7e8faa628a471da8d32e7f31ae82dea8c5b947383677bad6d",
        "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
        "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
        "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
            "chars": 63027
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q3",
    "period_label": "2024 Q3",
    "date": "2024-10-31",
    "title": "Kvartalsrapport Q3 2024",
    "original_title": "BioInvent International AB: Delårsrapport januari-september 2024",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bd4cfcd01dd2b8b94214bd849bb5735a4&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
        "title": "Kvartalsrapport Q3 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a6f0722ec763ee02c5204b7bb5397531e",
        "date": "2024-10-31",
        "period": "2024-q3",
        "form_type": "interim-report",
        "report_key": "2024:q3",
        "filename": "BioInvent_Q3_2024_SE_Final.pdf",
        "text_chars": 64135,
        "sha256": "240176b82d9e84f7441753a319c02de449d5a7332909d6f0c16bdc5b0dc6d422",
        "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
        "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
        "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
            "chars": 64135
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q2",
    "period_label": "2024 Q2",
    "date": "2024-08-29",
    "title": "Kvartalsrapport Q2 2024",
    "original_title": "BioInvent International AB: Delårsrapport januari-juni 2024",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bb820dcd84852a821843b4d764b9a506c&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
        "title": "Kvartalsrapport Q2 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a8c9a195497c084357930d08809bd444d",
        "date": "2024-08-29",
        "period": "2024-q2",
        "form_type": "interim-report",
        "report_key": "2024:q2",
        "filename": "BioInvent_Q2_2024_SE_Final.pdf",
        "text_chars": 65072,
        "sha256": "d87a7337d230474edc9255512d8e54ec176e2ae3b84aa7701ad9a01665f29f65",
        "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
        "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
        "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
            "chars": 65072
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2024:q1",
    "period_label": "2024 Q1",
    "date": "2024-04-24",
    "title": "Kvartalsrapport Q1 2024",
    "original_title": "BioInvent International AB: Delårsrapport januari-mars 2024",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b7f72929e5278ad28f6fadbf66ec061a8&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2024,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
        "title": "Kvartalsrapport Q1 2024",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a02eeedd16b87572fea4fcf26b0036b83",
        "date": "2024-04-24",
        "period": "2024-q1",
        "form_type": "interim-report",
        "report_key": "2024:q1",
        "filename": "BioInvent_Q1_2024_SE_Final.pdf",
        "text_chars": 57224,
        "sha256": "2330486ede597bccc52644461b86760db9c1fe658e5b7f0be2699431033a1d77",
        "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
        "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
        "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
            "chars": 57224
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:annual",
    "period_label": "2023 Årsredovisning",
    "date": "2024-04-04",
    "title": "Årsredovisning 2023",
    "original_title": "BioInvent International AB publicerar Årsredovisning 2023",
    "category": "Bokslut och Verksamhetsberättelse",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b5a27e4b656010db5805548be94869731&lang=sv&src=listed",
    "language": "sv",
    "report_type": "annual-report",
    "fiscal_year": 2023,
    "quarter": "annual",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-arsredovisning-2023",
        "title": "Årsredovisning 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a364100d8e3ca8d4be33a4e4eb14893b9",
        "date": "2024-04-04",
        "period": "2023-annual",
        "form_type": "annual-report",
        "report_key": "2023:annual",
        "filename": "BioInvent_AR_2023_SE.pdf",
        "text_chars": 253055,
        "sha256": "ed832cbeb1c10ece3a28450f47b49f338d8d1000b6e892991e84f7de368cbd3f",
        "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2023",
        "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2023",
        "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
            "chars": 178243
          },
          {
            "number": 2,
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
            "chars": 74810
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q4",
    "period_label": "2023 Q4",
    "date": "2024-02-22",
    "title": "Kvartalsrapport Q4 2023",
    "original_title": "BioInvent International AB Bokslutskommuniké 1 januari - 31 december 2023",
    "category": "Bokslutskommuniké",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bcad389850ce081669e8db0814075b534&lang=sv&src=listed",
    "language": "sv",
    "report_type": "year-end-report",
    "fiscal_year": 2023,
    "quarter": "q4",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
        "title": "Kvartalsrapport Q4 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a2412234949072bf59eac8ed22b6f1633",
        "date": "2024-02-22",
        "period": "2023-q4",
        "form_type": "year-end-report",
        "report_key": "2023:q4",
        "filename": "BioInvent_Q4_2023_SE_21_Februari.pdf",
        "text_chars": 59858,
        "sha256": "2d189019d4289cc37d2484e846ec7a2e9eb1432009e169b77e34fc954b2566e7",
        "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
        "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
        "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
            "chars": 59858
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q3",
    "period_label": "2023 Q3",
    "date": "2023-10-26",
    "title": "Kvartalsrapport Q3 2023",
    "original_title": "BioInvent International AB: Delårsrapport januari-september 2023",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=be3c96a549266656b51480317ea317825&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q3",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
        "title": "Kvartalsrapport Q3 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a4d494801f274a18bac47cb87692323de",
        "date": "2023-10-26",
        "period": "2023-q3",
        "form_type": "interim-report",
        "report_key": "2023:q3",
        "filename": "BioInvent_Q3_2023_SE.pdf",
        "text_chars": 55909,
        "sha256": "f088a9b62e0de2fddf99459d82055070e218251219008656016d322dc900782e",
        "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
        "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
        "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
            "chars": 55909
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q2",
    "period_label": "2023 Q2",
    "date": "2023-08-30",
    "title": "Kvartalsrapport Q2 2023",
    "original_title": "BioInvent International AB: Delårsrapport januari-juni 2023",
    "category": "Halvårsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=bf4bf34de03398ac4aa733181ca29a635&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q2",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
        "title": "Kvartalsrapport Q2 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/a2ca36c1ee58d29ec5d20efefaa15b8d0",
        "date": "2023-08-30",
        "period": "2023-q2",
        "form_type": "interim-report",
        "report_key": "2023:q2",
        "filename": "BioInvent_Q2_2023_SE_Final.pdf",
        "text_chars": 57056,
        "sha256": "266f99d8d9266ae077b85ffdfca158499eff19828176065eb8f8742e17c79dad",
        "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
        "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
        "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
            "chars": 57056
          }
        ]
      }
    ],
    "alternatives": []
  },
  {
    "report_key": "2023:q1",
    "period_label": "2023 Q1",
    "date": "2023-04-26",
    "title": "Kvartalsrapport Q1 2023",
    "original_title": "BioInvent International AB: Delårsrapport januari-mars 2023",
    "category": "Interimsrapport",
    "source": "Nasdaq Nordic",
    "source_class": "nasdaq-report",
    "source_url": "https://view.news.eu.nasdaq.com/view?id=b66bfb93a046b6bf82a485c034c6d0a45&lang=sv&src=listed",
    "language": "sv",
    "report_type": "interim-report",
    "fiscal_year": 2023,
    "quarter": "q1",
    "documents": [
      {
        "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
        "title": "Kvartalsrapport Q1 2023",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://attachment.news.eu.nasdaq.com/afbe6ff197068f6b7d4cbebf39b901af2",
        "date": "2023-04-26",
        "period": "2023-q1",
        "form_type": "interim-report",
        "report_key": "2023:q1",
        "filename": "BioInvent_Q1_2023_SE_Final.pdf",
        "text_chars": 53310,
        "sha256": "dd69154f612588fe8b682c646a8b90d596286f7c55ae6eb5c35ca0596f7bdbe9",
        "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
        "absolute_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
        "txt_url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
        "absolute_txt_url": "https://spela.port0.org/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
        "parts": [
          {
            "number": 1,
            "url": "/company/bioinvent-international/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
            "chars": 53310
          }
        ]
      }
    ],
    "alternatives": []
  }
]